Danaher
- Market cap
- 153.60B
- P/E (TTM)i
- 38.81
- P/Bi
- 2.92
- EPSi
- 5.05
- Div yieldi
- 0.66%
- 52W posi
- 72%
Anonymous reader poll. Unscientific, not investment advice.
About Danaher
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
- Founded
- 1984
- CEO
- Ms. Julie A. Sawyer Montgomery
- Employees
- 60,000
- Headquarters
- Washington, District of Columbia, United States of America
- Fiscal year end
- 12-31
- Website
- danaher.com
Company profile
- Exchange
- US
- Symbol
- DHR
- Market-cap rank
- #143
- Listing date
- 1970-01-01
- Market cap
- 153.60B
- Float cap
- 136.74B
- Shares out
- 702.99M
- Float shares
- 625.85M
Sectors & themes
Quote time 2026-10-08 09:15:12 · For reference only, not investment advice and not tailored to your situation.